Arax Advisory Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
+50,762
New +$219K ﹤0.01% 1994
2026
Q1
Sell
-46
Closed -$192 4198
2025
Q4
$192 Buy
+46
New +$178 ﹤0.01% 3730
2024
Q4
Sell
-690
Closed -$654 2667
2024
Q3
$654 Hold
690
﹤0.01% 2359
2024
Q2
$1.09K Buy
+690
New +$1K ﹤0.01% 2144

Other funds holding PGEN

Arax Advisory Partners's PGEN Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Precigen (PGEN) in Q2 2026: 50,762 shares worth $289K. The stake represents ﹤0.01% of the portfolio and ranks #1994 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in PGEN as recently as Q4 2025.

Arax Advisory Partners first reported a position in PGEN in Q2 2024 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Arax Advisory Partners held 50,762 shares of Precigen worth $289K as of Q2 2026.
  • Precigen was a new Arax Advisory Partners position in Q2 2026.
  • Precigen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1994 holding.
  • Arax Advisory Partners first reported a position in Precigen in Q2 2024 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.